Strides Pharma Science Limited

STAR.NS·NSE·Healthcare
Compare
1,007.60−6.60 (−0.65%)today
At close: Nov 5, 3:30 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,014.20
Open1,025.00
Day range993.601,028.10
52-week range768.651,260.90
Off day high−1.99%
Off 52-week high−20.09%
Volume438.71K
Avg. volume (3M)421.02K
Market cap92.87B
EPS (TTM)66.91
Forward P/E11.72
P/E ratio (TTM)15.06
Dividend yield0.49% (5.00)
Beta (5Y)0.36
Shares outstanding92.17M
Short interest—
Earnings dateJul 28, 2025 (est.)
Analyst target1,338.67
Profit margin11.83%

Against its peers

Compare in full ›
STAR.NS TAK 1795.TW SHILPAMED.BO NATCOPHARM.NS MOREPENLAB.NS
Market cap 92.87B 67.28B 44.76B 183.46B 156.27B 53.21B
P/E (TTM) 15.1 300.9 11.8 66.4 12.6 28.3
Forward P/E 11.7 39.7 7.1 45.0 16.8 —
Price/book 2.7 1.4 1.9 7.1 1.5 3.9
Dividend yield 0.49% 2.93% 1.61% 0.06% 0.75% 0.20%
1-year change +7.74% +54.40% −42.88% +151.72% −4.67% +112.26%
Today −0.65% +1.49% +5.66% +0.61% +1.00% −4.17%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Latest news

All STAR.NS news ›
News18·Positive

Strides Pharma Science Q2 profit up 2 pc at Rs 134 cr

New Delhi, Oct 29 (PTI) Strides Pharma Science Ltd on Thursday reported a 2 per cent rise in its profit after tax (PAT) for the second quarter ended September to Rs 134.1 crore, driven by revenue growth. The pharma company had posted a net…

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance